Event Type
Disclosure
Voluntary
Variant
8-K
Other Events On June 5, 2025, Theravance Biopharma R&D IP, LLC, Theravance Biopharma US, LLC and Theravance Biopharma Ireland Limited, subsidiaries of the Regis